Related Experiment Video
Updated: Jun 19, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Are stem cells a cure for diabetes?
Michael D McCall1, Christian Toso, Emmanuel E Baetge
1Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
With the already heightened demand placed on organ donation, stem cell therapy has become a tantalizing idea to provide glucose-responsive insulin-producing cells to Type 1 diabetic patients as an alternative to islet transplantation. Multiple groups have developed varied approaches to create a population of cells with the appropriate characteristics. Both adult and embryonic stem cells have received an enormous amount of attention as possible sources of insulin-producing cells. Although adult stem cells lack the pluripotent nature of their embryonic counterparts, they appear to avoid the ethical debate that has centred around the latter. This may limit the eventual application of embryonic stem cells, which have already shown promise in early mouse models. One must also consider the potential of stem cells to form teratomas, a complication which would prove devastating in an immunologically compromised transplant recipient. The present review looks at the progress to date in both the adult and embryonic stem cells fields as potential treatments for diabetes. We also consider some of the limitations of stem cell therapy and the potential complications that may develop with their use.
Insights
Stem cell therapy offers a promising alternative to organ donation for Type 1 diabetes, aiming to generate insulin-producing cells. Research explores both adult and embryonic stem cells, considering their potential and limitations for diabetic patients.
Area of Science:
- Biomedical research
- Regenerative medicine
- Endocrinology
Background:
- Type 1 diabetes requires ongoing management due to the pancreas's inability to produce insulin.
- Islet transplantation is limited by organ donor availability.
- Stem cell-derived cells offer a potential alternative for insulin replacement therapy.
Purpose of the Study:
- To review the progress in utilizing adult and embryonic stem cells for diabetes treatment.
- To evaluate the potential of stem cell therapy as an alternative to islet transplantation.
- To discuss the limitations and potential complications of stem cell therapy for diabetes.
Main Methods:
- Review of current research on adult stem cells for insulin production.
- Review of current research on embryonic stem cells for insulin production.
- Analysis of ethical considerations and potential risks, such as teratoma formation.
Main Results:
- Both adult and embryonic stem cells show promise in generating insulin-producing cells.
- Embryonic stem cells have demonstrated potential in early mouse models.
- Adult stem cells avoid the ethical debate surrounding embryonic stem cells.
Conclusions:
- Stem cell therapy is a developing field for treating Type 1 diabetes.
- Further research is needed to overcome limitations and ensure safety, including teratoma risk.
- The choice between adult and embryonic stem cells involves balancing potential benefits and ethical considerations.
More Related Videos
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
Stem Cell Culture
iPS Cell Differentiation
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic cells are...

